Jenburkt Pharmaceuticals Ltd — Quarterly Results & Earnings

₹955.45

+0.34%

Profit Growth YoY5.83%Latest quarter

Sales Growth YoY10.53%Latest quarter

Sales CAGR 5Y4.99%5 year compound

Profit CAGR 5Y16.18%5 year compound

📋

Quarterly Performance

YoY Profit Growth+5.83%

📈 Moderate growth

YoY Sales Growth+10.53%

✅ Strong growth

OPM 5Y Average

Operating profit margin

22.75%

EPS Growth 5Y

17.09%

Interest Coverage

Higher = safer debt servicing

105.25

ROE

19.87%

ROCE

27.18%

💡

Growth Analysis

Jenburkt Pharmaceuticals Ltd reported YoY profit growth of 5.83% and revenue growth of 10.53% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 4.99% and profits at 16.18% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Jenburkt Pharmaceuticals Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.